This article was originally published in The Tan Sheet
President Damon DeSantis assumes additional post of CEO with Chris Nast's appointment to vice chairman. DeSantis joined Rexall in 1983 and was named president in early 1998. Nast joined the company in 1995 as president and chief operating officer and assumed the role of CEO in 1997. Separately, the firm announces exclusive U.S. distribution rights to Italian firm Medestea International's Cellasene dietary supplement, which claims to "Help eliminate cellulite." The softgel product contains ginkgo biloba to help increase circulation and grape seed extract, an antioxidant. Launching in food, drug and mass market outlets nationwide in March, a 10-day supply retails for approximately $40. Rexall also has rights for Cellasene in several foreign markets
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC